Aron R. English sold $9.1M of LFCR
owner at LIFECORE BIOMEDICAL, INC. \DE\. 1,386,060 shares at an average of $6.59, traded May 23, 2025, filed May 28, 2025.
Score components
- +12Role10% owner
- +25Trade size$9.1M at market
- +20Share of holdings soldSold 84% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-078524, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 23, 2025 | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -96,137 | $6.75 | $649k | 1,554,103 | May 28, 2025 |
| May 27, 2025 | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -1,139,504 | $6.50 | $7.4M | 414,599 | May 28, 2025 |
| May 28, 2025 | SOpen-market sale Common Stockindirect: By: 22NW Fund, LP | -150,419 | $7.12 | $1.1M | 264,180 | May 28, 2025 |
Related signals
Other insiders at LIFECORE BIOMEDICAL, INC. \DE\ and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 21Weak | LFCRsell LIFECORE BIOMEDICAL, INC. \DE\ | Aron R. English owner | $86k 12,334 shares | -1% | |
| 27Weak | LFCRsell LIFECORE BIOMEDICAL, INC. \DE\ | Aron R. English owner | $362k 51,496 shares | -3% | |
| 26Weak | LFCRsell LIFECORE BIOMEDICAL, INC. \DE\ | Aron R. English owner | $290k 41,091 shares | -2% | |
| 35Weak | LFCRbuy LIFECORE BIOMEDICAL, INC. \DE\ | Paul Josephs Chief Executive Officer | $98k 17,000 shares | +3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.